Geron Corporation
(NASDAQ : GERN)

( )
GERN PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
Loading GERN News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
-0.80%69.291.0%$931.38m
AMGNAmgen Inc.
-0.09%173.140.8%$656.50m
BIIBBiogen Inc.
-0.71%286.900.9%$536.61m
CELGCelgene Corporation
-1.42%119.441.0%$479.99m
REGNRegeneron Pharmaceuticals, Inc.
0.12%371.611.9%$348.38m
ALXNAlexion Pharmaceuticals, Inc.
0.83%129.892.0%$299.57m
TSROTESARO, Inc.
-0.05%190.2715.3%$198.98m
INCYIncyte Corporation
1.55%122.362.3%$170.12m
ILMNIllumina, Inc.
-0.75%162.153.9%$148.02m
VRTXVertex Pharmaceuticals Incorporated
-2.02%86.552.6%$140.07m
CLVSClovis Oncology, Inc.
-4.27%62.9916.4%$132.37m
EXELExelixis, Inc.
-0.04%23.115.5%$131.47m
AAgilent Technologies, Inc.
-0.54%51.351.7%$117.26m
ACADACADIA Pharmaceuticals Inc.
-0.20%39.2019.0%$93.83m
BMRNBioMarin Pharmaceutical Inc.
0.41%90.244.0%$89.98m

Company Profile

Geron Corp. discovers and develops therapeutic products for cancer. It is a clinical stage biopharmaceutical company, which develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. Geron was founded by Michael D. West on November 28, 1990 and is headquartered in Menlo Park, CA.